Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Anixa Biosciences, Inc. - Common Stock (NQ:ANIX)

2.650 +0.070 (+2.71%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 38,620
Open 2.660
Bid (Size) 2.530 (1)
Ask (Size) 2.830 (1)
Prev. Close 2.580
Today's Range 2.590 - 2.730
52wk Range 2.070 - 4.200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent
Anixa secures USPTO patent for its breast cancer vaccine using α-lactalbumin, enhancing its IP portfolio and expanding future immunotherapy options. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga

Performance

YTD
+11.8%
+11.8%
1 Month
-10.5%
-10.5%
3 Month
+21.0%
+21.0%
6 Month
-13.1%
-13.1%
1 Year
-16.1%
-16.1%

More News

Read More
EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines
Via Benzinga
EXCLUSIVE: Anixa Biosciences Poised To Receive US Patent For Ovarian Cancer Vaccine
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Recap: Anixa Biosciences Q1 Earnings
Via Benzinga
This ACNB Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
Via Benzinga
iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024
Via ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Anixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying
Via Benzinga
EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy
Via Benzinga
Exposures Product Safety
EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program
Via Benzinga
ANIX Stock Earnings: Anixa Biosciences Beats EPS for Q2 2024
Via InvestorPlace
7 Penny Biotech Stocks to Triple Your Investment
Via InvestorPlace
Anixa Biosciences, Inc. (NASDAQ: ANIX) Featured in Coverage of the EF Hutton Annual Global Conference
Via Investor Brand Network
Sidoti Events, LLC's Virtual May Micro-Cap Conference
Via ACCESSWIRE
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
Via AB Newswire
Sidoti Events, LLC's Virtual January Micro-Cap Conference
Via ACCESSWIRE
Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape?
Via Benzinga
3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023
Via InvestorPlace
Anixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says 'Exceeded Expectations'
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
The 3 Most Undervalued Cheap Stocks to Buy in September 2023
Via InvestorPlace
Could Anixa Biosciences (NASDAQ:ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
Via ACCESSWIRE
Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
Via Benzinga
Anixa Biosciences And 2 Other Penny Stocks Insiders Are Aggressively Buying
Via Benzinga

Frequently Asked Questions

Is Anixa Biosciences, Inc. - Common Stock publicly traded?
Yes, Anixa Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Anixa Biosciences, Inc. - Common Stock trade on?
Anixa Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Anixa Biosciences, Inc. - Common Stock?
The ticker symbol for Anixa Biosciences, Inc. - Common Stock is ANIX on the Nasdaq Stock Market
What is the current price of Anixa Biosciences, Inc. - Common Stock?
The current price of Anixa Biosciences, Inc. - Common Stock is 2.650
When was Anixa Biosciences, Inc. - Common Stock last traded?
The last trade of Anixa Biosciences, Inc. - Common Stock was at 04/14/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.